Newly christened AccelaRAD unveiled at HIMSS 2009 a service that allows patients unprecedented control over their medical images. The service, called SeeMyRadiology.com, is designed to provide patients the opportunity to create personalized libraries of images in a centralized location. Using this service, patients own their digital medical images, choosing which ones to easily and securely share with whom, particularly physicians.
Newly christened AccelaRAD unveiled at HIMSS 2009 a service that allows patients unprecedented control over their medical images. The service, called SeeMyRadiology.com, is designed to provide patients the opportunity to create personalized libraries of images in a centralized location. Using this service, patients own their digital medical images, choosing which ones to easily and securely share with whom, particularly physicians.
The service can also be used by physicians to send medical images to other facilities. All they need do is log onto the URL, upload images, then advise physicians at the facility where they are referring their patients that the images are available for downloading.
SeeMyRadiology.com can be branded with an imaging site’s name to enhance recognition, according to AccelaRAD, formerly known as Neurostar, which is framing the application as a major step toward realizing the benefits of comprehensive electronic medical records (EMRs). Developed in collaboration with The Ohio State University Medical Center in Columbus and Piedmont Hospital in Atlanta, SeeMyRadiology.com includes a toolkit enabling seamless standards-based image integration with a full range of PACS, EMRs and personal health records systems.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.